Royalty Pharma Plc (RPRX) — Working Capital to Net Assets Ratio
Royalty Pharma Plc (RPRX) has a Working Capital to Net Assets ratio of 9.0% as of March 2026. Working capital of $890.13 Million (current assets of $1.43 Billion minus current liabilities of $535.68 Million) is measured against net assets of $9.94 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See RPRX net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Royalty Pharma Plc Working Capital to Net Assets (2014–2025)
This chart shows how Royalty Pharma Plc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 9.0%, reflecting working capital of $890.13 Million against net assets of $9.94 Billion USD. Check RPRX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Royalty Pharma Plc (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Royalty Pharma Plc from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Royalty Pharma Plc market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -0.2% | $-17.21 Million | $9.71 Billion | $619.00 Million | $636.21 Million | ▼ -5.5 pp |
| 2024 | 5.3% | $548.52 Million | $10.34 Billion | $1.80 Billion | $1.25 Billion | ▼ -5.7 pp |
| 2023 | 11.0% | $1.11 Billion | $10.08 Billion | $1.27 Billion | $161.38 Million | ▼ -3.5 pp |
| 2022 | 14.6% | $1.39 Billion | $9.53 Billion | $2.55 Billion | $1.17 Billion | ▼ -11.8 pp |
| 2021 | 26.4% | $2.71 Billion | $10.25 Billion | $2.88 Billion | $171.25 Million | ▲ +10.5 pp |
| 2020 | 16.0% | $2.39 Billion | $14.97 Billion | $2.70 Billion | $307.89 Million | ▲ +7.8 pp |
| 2019 | 8.1% | $498.65 Million | $6.14 Billion | $832.07 Million | $333.42 Million | ▼ -36.4 pp |
| 2018 | 44.6% | $2.03 Billion | $4.55 Billion | $2.61 Billion | $580.17 Million | ▼ -12.8 pp |
| 2017 | 57.4% | $2.56 Billion | $4.47 Billion | $2.95 Billion | $383.41 Million | ▼ -3.3 pp |
| 2016 | 60.7% | $2.71 Billion | $4.46 Billion | $3.00 Billion | $297.32 Million | ▲ +2.6 pp |
| 2015 | 58.1% | $2.73 Billion | $4.70 Billion | $3.04 Billion | $314.39 Million | ▼ -41.8 pp |
| 2014 | 99.9% | $43.98 Million | $44.02 Million | $46.91 Million | $2.92 Million | — |